Receptor protein found to be a key player in prostate cancer cells’ drug resistance

Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells’ resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that has spread beyond the prostate.

Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds | Psychedelic Invest

Vancouver, Canada, Feb. 20, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of

February 20, 2024

Press Ganey Brings AI-Powered Patient Insights to Epic EHR

What You Should Know: – Press Ganey, a leader in experience measurement, data analytics, and insights, today announced an expansion to its PX Connect Suite,

August 16, 2024

Lupus Organ Damage Most Often Comes Early

The biggest risks for organ damage for patients with systemic lupus erythematosus (SLE) come in the first year after diagnosis, analysis of a long-running registry

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.